Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

How pneumonia can reveal undiagnosed blood cancer (opens in a new tab)

medicalxpress.com · 2026-09-30

Short answerEvidenceSource

Short answer

Mixed

Mixed.

2 key claims are not backed by the study. 2 other points were not covered by the paper.

  • 3 supported
  • 2 not supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Two claims aren't supported by the study. Three of seven check out. Two claims the study doesn't address.

  • 3 supported
  • 2 not supported
  • 2 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7Not supportedThe article says a doctoral thesis from the same research group also shows that pneumococcal serotypes covered by the childhood vaccine have decreased sharply but have largely been replaced by other serotypes against which the vaccine offers no protection.View evidenceHide evidence

Why this verdict

The supplied paper profile contains no evidence about a doctoral thesis, childhood pneumococcal vaccination, serotype replacement, or vaccine-covered serotype trends. This claim may concern a separate work, but it is not supported by the provided paper profile.

Claim 2 of 7Not supportedThe story says the results show adult pneumococcal vaccine recommendations need to take into account which vaccines are used in children and which bacterial serotypes subsequently circulate in the community.View evidenceHide evidence

Why this verdict

The supplied paper profile does not discuss adult pneumococcal vaccine recommendations, childhood vaccine programs, or circulating serotypes. It therefore cannot support the story’s vaccine-policy implication, which appears to come from material outside the profiled paper.

Claim 3 of 7Not coveredThe study followed 156 individuals who developed invasive pneumococcal disease and required hospital care in Region Västra Götaland, Sweden, between 2018 and 2023, and compared them with 64 age- and sex-matched controls.View evidenceHide evidence

As stated156 patients; 64 controls

Why this verdict

The abstract-level profile supports the sample sizes of 156 adult IPD patients and 64 age-/sex-matched controls. However, the more specific details that they required hospital care in Region Västra Götaland, Sweden, between 2018 and 2023 are not available in the supplied abstract-level profile, so the claim as fully stated cannot be verified at this depth.

1

Study evidence

Prevalence of serum monoclonal immunoglobulin (M protein) during acute IPD was higher than in matched controls.22% (31/141) in patients without prior hematologic malignancy vs 5% in controls; p = 0.002

“In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients”
2

Study evidence

M protein was detected during acute IPD in 22% (31/141) of patients without previously known hematological malignancy compared with 5% of controls (p = 0.002).22% vs 5% (p = 0.002)

“Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD…”
Claim 4 of 7Not coveredEight patients were found to have immunodeficiency, seven of whom were able to start preventive treatment against new, severe infections, and these findings were considerably less common in the control group.View evidenceHide evidence

As stated8 immunodeficient patients; 7 started preventive treatment

Why this verdict

The profile supports that convalescent low IgA/IgG2/IgG4 levels were more common in IPD patients than controls and that seven patients started immunoglobulin replacement therapy. But the story’s specific statement that eight patients were found to have immunodeficiency is not present in the abstract-level profile, which reports three primary immunoglobulin-deficiency diagnoses. The exact 'eight' count and the 'preventive treatment' characterization are therefore not verifiable from the supplied abstract-level evidence.

1

Study evidence

In convalescence (2–4 months post-IPD), 16–20% of patients had IgA, IgG2, or IgG4 below reference intervals versus 0–2% of matched non-IPD controls.16–20% vs 0–2% (patients vs controls)

“Patients were sampled … in the convalescence phase 2-4 months after acute infection (n = 76).”
2

Study evidence

M protein was detected during acute IPD in 22% (31/141) of patients without previously known hematological malignancy compared with 5% of controls (p = 0.002).22% vs 5% (p = 0.002)

“Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD…”
Claim 5 of 7SupportedSevere pneumococcal disease requiring hospitalization, most commonly pneumonia, can be a sign of previously undiagnosed blood cancer and immunodeficiency in adult patients, according to a study from the University of Gothenburg.View evidenceHide evidence

Why this verdict

The paper profile supports the core framing that adult invasive pneumococcal disease may unmask previously undiagnosed hematologic malignancy/MGUS and immunodeficiency, based on higher M-protein prevalence and immunoglobulin abnormalities in IPD patients versus controls. The profile does not specifically verify the article’s 'most commonly pneumonia' phrasing at abstract depth, but the main claim is consistent with the paper’s stated conclusions.

1

Study evidence

Prevalence of serum monoclonal immunoglobulin (M protein) during acute IPD was higher than in matched controls.22% (31/141) in patients without prior hematologic malignancy vs 5% in controls; p = 0.002

“In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients”
2

Study evidence

In convalescence (2–4 months post-IPD), 16–20% of patients had IgA, IgG2, or IgG4 below reference intervals versus 0–2% of matched non-IPD controls.16–20% vs 0–2% (patients vs controls)

“Patients were sampled … in the convalescence phase 2-4 months after acute infection (n = 76).”
Claim 6 of 7SupportedIn the pneumococcal disease group, one in four individuals had M protein in their blood, and examinations led to seven patients being diagnosed with blood cancer and another 12 being diagnosed with a condition that can sometimes progress to blood cancer.View evidenceHide evidence

As statedone in four; 7 blood cancers; 12 precursor conditions

Why this verdict

The paper profile reports M protein in 22% of eligible IPD patients during acute infection versus 5% of controls, followed by seven hematologic malignancy diagnoses and 12 MGUS diagnoses. The story’s 'one in four' wording is a rounded-up lay expression for the reported 22%, but the underlying direction and diagnostic counts are supported.

1

Study evidence

Prevalence of serum monoclonal immunoglobulin (M protein) during acute IPD was higher than in matched controls.22% (31/141) in patients without prior hematologic malignancy vs 5% in controls; p = 0.002

“In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients”
2

Study evidence

M protein was detected during acute IPD in 22% (31/141) of patients without previously known hematological malignancy compared with 5% of controls (p = 0.002).22% vs 5% (p = 0.002)

“Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD…”
Claim 7 of 7SupportedThe researchers say screening for M proteins and antibody levels in adults with invasive pneumococcal disease should be considered because the disease can reveal previously undiagnosed blood cancer and immunodeficiency.View evidenceHide evidence

Why this verdict

This closely matches the authors’ abstract-level conclusion that assessment of M protein and immunoglobulin levels could be considered in adults with IPD because IPD may unmask previously undiagnosed B-cell malignancy or immunodeficiency. The story presents this as a consideration rather than a firm screening mandate, which is consistent with the paper profile.

1

Study evidence

M protein was detected during acute IPD in 22% (31/141) of patients without previously known hematological malignancy compared with 5% of controls (p = 0.002).22% vs 5% (p = 0.002)

“Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD…”
2

Study evidence

Prevalence of serum monoclonal immunoglobulin (M protein) during acute IPD was higher than in matched controls.22% (31/141) in patients without prior hematologic malignancy vs 5% in controls; p = 0.002

“In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Convalescent immunoglobulin analyses were based on a subset of patients, with convalescent samples available for 76 of the 156 IPD patients.

    This limitation is material to interpreting the immunoglobulin-deficiency findings, but the story presentation does not mention that convalescent testing was performed in only a subset.

    From prospective multicenter observational cohort with matched controls; Prospective multicenter observational study

  • The paper profile does not contain serotype-replacement findings or adult vaccine-recommendation evidence.

    The story includes claims about a doctoral thesis and pneumococcal serotype shifts, but these are outside the supplied paper profile and therefore are not reflected as material elements of this profiled paper.

5 things the story did carry across
  • Adult IPD patients had a higher prevalence of serum monoclonal immunoglobulin/M protein than matched controls.
  • M-protein detection during IPD was followed by new diagnoses of hematologic malignancy and MGUS in some patients.
  • Convalescent immunoglobulin subclass abnormalities were more common in IPD patients than controls, and some patients received immunodeficiency diagnoses or immunoglobulin replacement therapy.
  • The authors’ practice-oriented implication was cautious: assessment of M protein and Ig levels could be considered in adults with IPD.
  • The study was observational and supports an unmasking/association interpretation rather than proving that IPD causes blood cancer or immunodeficiency.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoAdults with invasive pneumococcal disease (IPD) have an increased prevalence of previously unrecognized monoclonal immunoglobulins (M protein) compared with age/sex-matched controls, and IPD can unmask underlying hematologic malignancy/MGUS.Prospective multicenter observational cohort with age-/sex-matched non-IPD controlsExpand

In plain English

Prospective multicenter study of 156 adults with invasive pneumococcal disease (IPD) and 64 age-/sex-matched controls found higher prevalence of monoclonal immunoglobulin (M protein) detected in serum during acute IPD (22% of patients without prior hematologic malignancy vs 5% of controls, p = 0.002). Follow-up assessments identified subsequent hematologic malignancies and MGUS among those with M protein; convalescent low levels of select Ig subclasses were more frequent in patients than controls. Authors conclude that testing for M protein and Ig levels may reveal previously unrecognized B-cell malignancy or immunodeficiency in adults presenting with IPD.

Key findings

  • Prevalence of serum monoclonal immunoglobulin (M protein) during acute IPD was higher than in matched controls.22% (31/141) in patients without prior hematologic malignancy vs 5% in controls; p = 0.002
  • Detection of M protein during IPD was followed by clinical diagnoses of hematologic malignancy or MGUS in a subset of patients.
“In this prospective study, we assessed the prevalence of monoclonal Ig (M protein) and analyzed Ig concentrations in sera from 156 adult IPD patients”
What this piece can’t prove
  • The abstract does not report detailed timing of downstream diagnostic workup or the proportion of all M-protein–positive patients who completed follow-up diagnostics.

2 further details could not be confirmed from the summary.

2human in vivoIn convalescence after IPD, a substantial fraction of patients show low immunoglobulin subclasses (e.g., IgA, IgG2, IgG4) compared with controls, and some are diagnosed with primary Ig deficiency or start Ig replacement therapy.prospective multicenter observational cohort with matched controlsExpand

In plain English

In a multicenter prospective cohort of adult IPD patients, 76 individuals were sampled in convalescence (2–4 months post-infection) and compared with 64 age- and sex-matched controls; convalescent levels of IgA, IgG2, or IgG4 were below reference intervals in 16–20% of patients versus 0–2% of controls. Three patients were diagnosed with a primary immunoglobulin deficiency and seven patients initiated immunoglobulin replacement therapy.

Key findings

  • In convalescence (2–4 months post-IPD), 16–20% of patients had IgA, IgG2, or IgG4 below reference intervals versus 0–2% of matched non-IPD controls.16–20% vs 0–2% (patients vs controls)
  • Three patients were diagnosed with a primary immunoglobulin deficiency and seven patients started immunoglobulin replacement therapy.3 patients diagnosed; 7 patients initiated therapy
“Patients were sampled … in the convalescence phase 2-4 months after acute infection (n = 76).”
What this piece can’t prove
  • Convalescent sample size (n = 76) is limited for estimating subclass-specific prevalences with precision.
  • Reference-interval definitions and laboratory assay methods are unspecified, limiting interpretation of what 'below reference intervals' signifies.
  • Unclear selection criteria for the convalescent subset and potential selection bias in who returned for convalescent sampling.

2 further details could not be confirmed from the summary.

3otherPractical implication: assessment of M protein and immunoglobulin levels could be considered in adults with IPD to detect occult B-cell malignancy or immunodeficiency.Prospective multicenter observational studyExpand

In plain English

The authors report a prospective multicenter observational study of 156 adults with invasive pneumococcal disease (IPD) and 64 matched controls and conclude that assessment of monoclonal immunoglobulin (M protein) and immunoglobulin levels could be considered in adults with IPD because an episode of IPD may unmask previously undiagnosed B‑cell malignancy or immunodeficiency. This recommendation is based on higher detection of M protein during acute IPD, subsequent diagnoses of hematologic malignancy and MGUS, and frequent low convalescent isotype levels in a subset of patients.

Key findings

  • M protein was detected during acute IPD in 22% (31/141) of patients without previously known hematological malignancy compared with 5% of controls (p = 0.002).22% vs 5% (p = 0.002)
  • Following IPD, seven patients were diagnosed with hematological malignancies and 12 with MGUS.7 new hematologic malignancies; 12 MGUS diagnoses (counts)
“Our findings suggest that assessment of M protein and Ig levels could be considered in adults with IPD…”
What this piece can’t prove
  • The recommendation to consider testing is an interpretive statement derived from observational data rather than from an interventional study.
  • Convalescent data were available for a subset of patients (n=76), limiting assessment of persistence of abnormalities.
  • Numbers of subsequent hematologic malignancy and primary immunodeficiency diagnoses were small, limiting precision of risk estimates.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

Candidate

Author Correction: Inference limits in partially observable Ethereum blockchains

Scientific Reports · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author Correction: N-mixture models with camera trap imagery produce accurate abundance estimates of ungulates

Scientific Reports · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author response of: Deeds and Words: The Role of Behavior-Advocacy Consistency of Climate Scientists in Communicating the Scientific Consensus on Climate Change. Round#1

Peer Community in Registered Reports · 2026 · Crossref

Source (opens in a new tab)

And 31 more candidates considered.